Phase I Study of Comparing Single Dose JS005 (Recombinant Humanized Monoclonal Antibody Against IL-17A) With Placebo in Tolerability, Safety, Immunogenicity and Pharmacokinetic in Healthy Volunteers
PHASE1
JS005-001 is one randomized, double-blind, placebo-controlled study to eval...
A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis
PHASE3
This is a multicenter, randomized, double-blind, parallel, placebo-controll...
Status
Completed
Location
The First Affiliated Hospital of Bengbu Medical College